Moneycontrol
HomeNewscoronavirusDelhi: Registration begins for COVID-19 vaccination of 15-18 age group population

Delhi: Registration begins for COVID-19 vaccination of 15-18 age group population

According to the guidelines, which will come into effect from January 3, those aged 15 and above will be able to register on CoWIN. In other words, "all those whose birth year is 2007" or before, shall be eligible.

January 01, 2022 / 22:03 IST
Story continues below Advertisement
(Representational image)

Registration for vaccination of children against COVID-19 in the 15-18 age group began in Delhi on Saturday, as centres here have geared up to start inoculating the younger population from January 3.

According to official documents shared by sources, the cohort size for vaccination in this category is 10 lakh as per the Registrar General of India's figures.

Story continues below Advertisement

Union Health Minister Mansukh Mandaviya took to Twitter to request people to register eligible children in their families.

"On the occasion of New Year, registration is being started on CoWIN portal for immunisation of children against COVID-19 in the age group of 15 to 18 years from today. I request the family members to register the eligible children for vaccination," Mr Mandaviya tweeted using the hashtag 'SabkoVaccineMuftVaccine'.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show